← Leaderboards
William D Merryman
Vanderbilt University
$11,751,914
Attributed
$12,131,429
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,131,429 · 8
By mechanism
R01$5,766,918 · 5
R35$5,540,012 · 1
K25$724,500 · 1
R56$99,999 · 1
Top collaborators
- Giovanni Ferrari1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Gautam Bhave$2,693,396
- Matthew Ryan Bersi$845,981
- Mark P De Caestecker$8,014,159
- Nathaniel Craig Bloodworth$138,429
- Tessa M Huffstater$69,453
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPreventIn VitroHeart Valve DiseasesPhenotypeFutureFibroblastsAnimal ModelCardiacPathologyTreatment StrategyPositioning AttributeMyocardial InfarctionFibrosisLaboratoriesMyofibroblastAffectInterstitial CellPulmonary Arterial HypertensionElderlyMolecularProgramsCostCicatrix
Grant awards (30)
Decoupling mitral valve-left ventricular fibrotic remodeling in degenerative mitral regurgitation via serotonin 2B receptor$759,030
R01 · FY2025 · HL · contact PI
Systemically restricted 5-HT2B antagonists for pulmonary arterial hypertension$680,115
R01 · FY2025 · HL · contact PI
Cadherin-11 in calcific aortic valve disease$645,046
R01 · FY2025 · HL · contact PI
Cadherin-11 in calcific aortic valve disease$93,757
R01 · FY2025 · HL · contact PI
Systemically restricted 5-HT2B antagonists for pulmonary arterial hypertension$637,320
R01 · FY2024 · HL · contact PI
Cadherin-11 in calcific aortic valve disease$619,876
R01 · FY2024 · HL · contact PI
Cadherin-11 in calcific aortic valve disease$56,991
R01 · FY2024 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2023 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$76,947
R35 · FY2023 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2022 · HL · contact PI
Role of cadherin-11 in kidney fibrosis$99,999
R56 · FY2022 · DK · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$76,947
R35 · FY2022 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2021 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$37,195
R35 · FY2021 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2020 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2019 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,132
R35 · FY2018 · HL · contact PI
Mechanobiology of Cardiopulmonary Fibrosis$764,131
R35 · FY2017 · HL · contact PI
Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve Disease$386,800
R01 · FY2016 · HL · contact PI
Ultrasound Guided Mitral Valve Ablation$380,872
R01 · FY2016 · HL · contact PI
Ultrasound Guided Mitral Valve Ablation$381,100
R01 · FY2015 · HL · contact PI
Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve Disease$380,998
R01 · FY2015 · HL · contact PI
Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve Disease$379,064
R01 · FY2014 · HL · contact PI
Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve Disease$365,949
R01 · FY2013 · HL · contact PI
TGF-beta1 activity in the aortic valve$145,908
K25 · FY2013 · HL · contact PI
TGF-beta1 activity in the aortic valve$145,908
K25 · FY2012 · HL · contact PI
TGF-beta1 activity in the aortic valve$145,908
K25 · FY2011 · HL · contact PI
TGF-beta1 activity in the aortic valve$143,508
K25 · FY2010 · HL · contact PI
TGF-beta1 activity in the aortic valve$108,268
K25 · FY2009 · HL · contact PI
TGF-beta1 activity in the aortic valve$35,000
K25 · FY2009 · HL · contact PI